Abstract
We thank Keskin for the interest in our work and agree with his comments.
Specifically, we agree that all hepatitis B patients should be routinely assessed for other blood-borne viruses (hepatitis C virus, human immunodeficiency virus and delta hepatitis), and this is consistent with recently published Australian Consensus recommendations. However, it has been observed by our group and others that delta hepatitis is very rare or non-existent in Indigenous Australian populations, so the value of routine testing in this population is uncertain.
Specifically, we agree that all hepatitis B patients should be routinely assessed for other blood-borne viruses (hepatitis C virus, human immunodeficiency virus and delta hepatitis), and this is consistent with recently published Australian Consensus recommendations. However, it has been observed by our group and others that delta hepatitis is very rare or non-existent in Indigenous Australian populations, so the value of routine testing in this population is uncertain.
| Original language | English |
|---|---|
| Pages (from-to) | 1458 |
| Number of pages | 1 |
| Journal | Internal Medicine Journal |
| Volume | 52 |
| Issue number | 8 |
| Early online date | 16 Aug 2022 |
| DOIs | |
| Publication status | Published - Aug 2022 |
Keywords
- chronic hepatitis B
- indigenous health
- vaccination
- public health
- Australia
Fingerprint
Dive into the research topics of 'Author reply'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver